Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling for Male Androgenetic Alopecia
NCT07758400Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
Randomised trial of minoxidil in androgenetic alopecia (AGA) (7 arms). Primary endpoint: Target area non-vellus hair count at 24 weeks. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07758400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758400.